Murdoch Childrens Research Institute, The University of Melbourne, Royal Childrens Hospital, Parkville, Victoria, Australia.
J Thromb Haemost. 2010 Jun;8(6):1290-4. doi: 10.1111/j.1538-7836.2010.03847.x. Epub 2010 Mar 9.
Clinically significant age-related differences in the anticoagulation effect of heparin have previously been established in vitro as well as in different clinical settings in vivo. These differences were hypothesized to be due to the age-specific differences in binding of heparin to plasma proteins.
The aim of this project was to investigate global age-related differences in heparin binding to plasma proteins.
PATIENTS/METHODS: Heparin-binding proteins were identified by incubating heparin-coated magnetic beads with plasma samples from neonates, children and adults, and purifying the proteins that were bound to the beads in this reaction system.
These results provide the first preliminary evidence of age-related differences in the total number and concentration of proteins bound to heparin. The results also suggest, for the first time, that there are age-related differences of heparin binding to antithrombin and thrombin.
The results of this study, although preliminary, support and contribute to the explanation of the mechanism of age-related differences in the effect of heparin observed previously in vitro and in vivo.
此前已在体外以及不同的体内临床环境中证实肝素的抗凝作用存在与年龄相关的显著差异。这些差异的原因被假设为肝素与血浆蛋白结合的特异性年龄差异。
本项目旨在研究肝素与血浆蛋白结合的整体年龄相关性差异。
患者/方法:通过将肝素包被的磁珠与新生儿、儿童和成人的血浆样本孵育,并在该反应系统中纯化与珠结合的蛋白质,从而鉴定肝素结合蛋白。
这些结果首次提供了与年龄相关的肝素结合蛋白总数和浓度差异的初步证据。结果还首次表明,肝素与抗凝血酶和凝血酶的结合存在与年龄相关的差异。
尽管这项研究的结果尚属初步,但支持并有助于解释之前在体外和体内观察到的肝素作用与年龄相关差异的机制。